Neil Matthew Steven

机构：Swansea Bay University Health Board, University Hospitals Birmingham NHS Foundation Trust, University of Birmingham · ORCID：0000-0002-0571-5043

发表论文 161 篇 · 总被引 8027 次 · h-index 42

代表论文

Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma (2020 · Clinical Cancer Research · 被引 283)
Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH) (2021 · BMC Cancer · 被引 99)
Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH) (2021 · Research Square · 被引 78)
Head and neck mucosal melanoma: The United Kingdom national guidelines (2020 · European Journal of Cancer · 被引 67)
Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition (2024 · The Journal of Laryngology & Otology · 被引 57)
Current role of sentinel lymph node biopsy in the management of cutaneous melanoma: A UK consensus statement (2019 · Journal of Plastic Reconstructive & Aesthetic Surgery · 被引 49)